書籍詳細

第一章 原理と測定法

P.11 掲載の参考文献

• 1) 日本呼吸器学会肺生理専門委員会. 編. 呼吸機能検査ガイドライン-スパイロメトリー, フローボリューム曲線, 肺拡散能力-メディカルレビュー社 : 2004

• 2) 日本呼吸器学会COPDガイドライン第4版作成委員会. COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン第4版. メディカルレビュー社 : 2013

• 3) Holley HS, Milic-Emili J, Becklake NIR, Bates DV. Regional distribution of pulmonary ventilation and perfusion in obesity. J. Clin Invest 46 : 475-481, 1967

• 4) Tashkin DP. Celii B. Decramer M, Liu D, Burkhart D, Cassino C, Kesten S. Bronchodilator responsiveness in patients with COPD. Eur Respir J 31 : 742-750, 2008

• 5) Americall Thoracic Society. Standardization of spirometry 1994 Update. Am J Respir Crit Care Med 152 : 1107-1136, 1995
  pubmed

• 6) Kryger M, Bode F. Antic R, Anthonisen N. Diagnosis of obstruction of the upper and central airways. Am J Med 61 : 85-93, 1976
  pubmed

P.16 掲載の参考文献

• 1) 日本呼吸器学会肺生理専門委員会. 臨床呼吸機能検査 第7版, メディカルレビュー社 : 2008

P.24 掲載の参考文献

• 1) Milic-Emili J, Mead J, Turner JM. Topography of esophageal pressure as a function of posture in man. J Appl Physiol 19 : 212-226, 1964

• 2) Mansell A, Bryan C, Levison H. Airway closure in children. J Appl Physiol 33 : 711-714, 1972

• 3) Leblanc P, Ruff F, Milic-Emili J. Effect of age and body position on "airway closure" in man. J Appl Physiol 28 : 448-451. 1970

• 4) Anthonisen NR, Danson J, Robertson PC, Ross WR. Airway closure as a function of age. Resir Physiol 8 : 58-65. 1970

• 5) Dollfuss RE, Milic-Emili J, Bates DV. Regional ventilation of the lung studied with boluses of 133 Xenon. Respir Physiol 2 : 234-246. 1967

• 6) Buist AS. Early Detection of Airways Obstruction by the Closing Volume Technique. Chest 64 : 495-499, 1973
  pubmed

• 7) Buist AS, Ross BB. Predicted values for closing volumes using a modified single breath nitrogen test. Am Rev Respir Dis 107 (5) : 744-752, 1973
  pubmed

• 8) Comroe JH Jr, Fowler WS. Lung function studies. VI. Detection of uneven alveolar ventilation during a single breath of oxygen. Am J Med 10 : 408, 1951
  pubmed

• 9) Milic-Emili J, Torchio R, D'Angelo E. Closing volume : a reappraisal (1967-2007). Eur J Appl Physiol 99 : 567-583, 2007
  pubmed

• 10) Fowler WS. Lung function studies II. The respiratory deadspace. Am J Physiol 154 : 405-416, 2005

• 11) Robertson B. Lung surfactant. In : Robertson B, Van Calde L, Batenburgh J, eds. Pulmonary Surfactant, Elsevier, Amsterdam : 1984

• 12) D'Angelo E, Pecchiari M, Della Valle P, Koutsoukou A, Milic-Emili J. Effects of mechanical ventilation at low lung volume on respiratory mechanics and nitric oxide exhalation in normal rabbits. J Appl Physiol 99 : 433-444, 2005
  pubmed

P.29 掲載の参考文献

• 1) 金澤実. 1. 呼吸機能入門 : 日本呼吸器学会肺生理専門委員会, 編, 臨床呼吸機能検査 第7版. 株式会社メディカルレビュー社. 東京 : pp3-8, 2008

• 2) Crank J. The Mathematics of Diffusion, Oxford University Press. New York : 1975

• 3) Roughton FJW, Forster RE. Relative importance of diffusion and chemical reaction in determing rate of exchange of gases in the human lung. J Appl Physiol 11 : 290-302, 1957

• 4) Piiper J, Scheid P. Model for capillary-alveolar equilibration with special reference to O2 uptake in hypoxia. Respir Physiol 46 : 193-208, 1981
  pubmed

• 5) Comroe JH, Forster RE, Dubois AB, et al. The lung. In : Clinical physiology and pulmonary function tests, 2nd ed, Year book medical publishers. Chicago : 1962

• 6) Forster R. Interpretation of measurements of pulmonary diffusing capacity. In : Fenn W, Rahn H, eds. Handbook of Physiology. Vol. Respiration, American Physiological Society. Washinton DC : pp1453-1468, 1965

• 7) West J. Respiratory Physiology-the essentials, The Willams & Wilkins Company. Baltimore : 1974

• 8) 山口佳寿博. 肺拡散能力 : 日本呼吸器学会肺生理専門委員会. 編. 呼吸機能検査ガイドライン-スパイロメトリー, フローボリューム, 肺拡散能力-, 日本呼吸器学会東京 : pp26-41, 2004

• 9) 小林弘祐. 7. 拡散 : 日本呼吸器学会肺生理専門委員会. 編. 臨床呼吸機能検査 第7版. 株式会社メディカルレビュー社. 東京 : pp65-78. 2008

• 10) Meyer M, Scheid P, Riedl G. et al. Pulmonary diffusing capacities for O2 and CO measured by a rebreathing technique. J Appl Physiol 51 : 1643-1650, 1981

• 11) Ogilvie CM, Forster RE, Blakemore WS, et al. A standardized breath holding technique for the clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 36 : 1-17, 1957
  pubmed

• 12) Thompson BR, Kim Prisk G, Peyton P, et al. Inhomogeneity of ventilation leads to unpredictable errors in measured D (L) co. respir Physiol Neurobiol 146 : 205-214, 2005

• 13) Cotes JE, Dabbs JM, Elwood PC, et al. Iron-deficiency anaemia : its effect on transfer factor for the lung (diffusing capacity) and ventilation and cardiac frequency during sub-maximal exercise. Clin Sci 42 : 325-335, 1972
  pubmed

P.37 掲載の参考文献

• 1) 日本呼吸器学会肺生理専門委員会, 編, 呼吸機能検査ガイドラインII (血液ガス, パルスオキシメータ), メディカルレビュー社. 東京 : 2006

• 2) 日本呼吸器学会, 編. 臨床呼吸機能検査 第7版. メディカルレビュー社. 東京 : 2008

• 3) Harrison's Principles of Internal Medicine 17th Edition, McGraw-Hill Professional : 2008

• 4) ARDS Definitioll Task Force : Acute respiratory distress syndrome : the Berlin Definition. JAMA 307 : 2526, 2012
  pubmed

P.45 掲載の参考文献

• 1) 青柳貞雄ほか. イヤピース・オキシメータの改良. 技術と人間. 第31回日本ME学会大会資料集 : pp90-91, 1974

• 2) Kawagishi T, Kanaya N, Nakayama M, Kurosawa S, Namiki A. A comparison of the failure times of pulse oximeters during blood pressure cuff-induced hypoperfusions in volunteers. Anesth Analg 99 : 793-796, 2004
  pubmed

• 3) Mengelkoch LJ, Martin D, Lawler J. A review of the principles of pulse oximetry and acuracy of pulse oximeter estimates during exercise. Phys Ther 74 : 40-49, 1994

• 4) Triveri NS, Ghouri AF, Shah NK, Lai E, Barker SJ. Effects of motion, ambient light, and hypoperfusion on pulse oximeter function. J Clin Anesthsia 9 : 179-183, 1997

• 5) Brooks DB, Paulus DA, Winkle WE. Infrared heat lamps interfere with pulse oximeters. Aneasthesiology 61 : 630, 1984

• 6) Barker SJ, Tremper KK, Hyatt J. Effects of methelnoglobinemia on pulse oximetry and mixed venous oximetry. Anesth 70 : 112-117, 1989

P.53 掲載の参考文献

• 1) American Thoracic Society, European Respiratory Society. ATS/ERS recomInelldatiolls for standardized procedures for the online and offline Ineasurelnellt of exhaled lower respiratory nitric oxide and nasal nitric oxide. Am J Respir Crit Care Med 171 : 912-930, 2005
  pubmed

• 2) 松永和人 一ノ瀬正和. 呼気NO濃度測定の基礎と臨床. 検査と技術 10 : 1073-1079. 2008

• 3) 平野綱彦 功刀亜美 一ノ瀬正和. 新高速応答呼気一酸化窒素測定機器NA-623NとNIOX MINOとの比較. 呼吸 28 : 753-758. 2009

• 4) 喘息予防・管理ガイドライン2012. 社団法人日本アレルギー学会喘息, 予防・管理ガイドライン専門部会監修. 共和企画. 東京 : 2012

• 5) An official ATS clinical practice guideline, interpretation of exhaled nitric oxide levels (FENO) for clinical applications. Am J Respir Crit Care Med 184 : 602-615, 2011
  pubmed

• 6) Ichinose M, Sugiura H. Yamagata S, et al. Increase in reactive nitrogen species production in chronic obstructive pulmpnary disease airways. Am J Respir Crit Care Med 162 : 701-706, 2000

• 7) Matsunaga K. Hirano T, Kawayama T. et al. Reference ranges for exhaled nitric oxide fraction in healthy Japanese adult population. Allergol Int 59 : 363-367, 2010
  pubmed

• 8) Matsunaga K, Hirano T, Akamatsu K. et al. Exhaled nitric oxide cutoff values for asthma diagnosis according to rhinitis and smoking status in Japanese subjects. Allergol Int 60 : 331-337, 2011
  pubmed

• 9) Fabbri LM. Romagnoli M. Corbeua L, et al. Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease. Am J Respir Crit Care Med 167 : 418-424, 2003
  pubmed

• 10) Di Lorenzo G, Mansueto P, Ditta V. et al. Similarity and differences in patients with fixed airflow obstruction by asthma and by chronic obstructive pulmonary disease. Respir Med 102 : 232-238, 2008
  pubmed

• 11) 日本呼吸器学会COPDガイドライン第4版作成委員会, 編集. COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 第4版 メディカルレビュー社. 東京 : 2013

• 12) Akamatsu K, Matsunaga K, Sugiura H, et al. Improvelnent of airflow limitation by fluticasone propionate/salmeterol in chronic obstructive pulmonary disease. Front Pharmacol 2 : 36. 2011
  pubmed

• 13) Ichinose M, Takahashi T. Sugiura H, et al. Baseline airway hyperresponsiveness and its reversible component : role of airway inflammation and airway caliber. Eur Respir J 15 : 248-253, 2000
  pubmed

• 14) Green RH, Brightling CE, MacKenna S. et al. Asthma exacerbations and sputum eosinophil counts. Lancel 360 : 1715-1721, 2002

• 15) Smith AD, Cowan JO. Brassett KP, et al. Use of exhaled nitric oxide measurements to guide treatment in chronic asthma. N Engl J Med 352 : 2163-2173, 2005
  pubmed

• 16) Szefler SJ, Mitchell H, Sorkness CA, et al. Management of asthma based on exhaled nitric oxide in addition to guideline-based treatment forinner-city adolescents and young adults : a randomized controlled trial. Lancet 372 : 1065-1072, 2008

• 17) Barnes PJ, Dweik RA, Gelb AF. Exhaled nitric oxide in pulmonary diseases, a comprehensive review. Chest 138 : 682-692, 2010
  pubmed

• 18) Powell H, Murphy VE, Taylor DR, et al. Management of asthlna in pregnancy guided by measurement of fraction of exhaled nitric oxide : a double-blind, randomised controlled trial. Lancet 378 : 983-990, 2011
  pubmed

• 19) Hirano T, Matsunaga K, Sugiura H. et al. Persistent elevation of exhaled nitric oxide and modification of corticosteroid therapy in asthma. Respir Investig 51 : 84-91, 2013
  pubmed

• 20) Matsunaga K, Yanagisawa S, Hirano T, et al. Associated demographics of persistent exhaled nitric oxide elevation in treated asthmatics. Clin Exp Allergy 42 : 775-781, 2012
  pubmed

• 21) van Veen IH, Ten Brinke A. Sterk PJ, et al. Exhaled nitric oxide predicts lung function decline in difficult-to-treat asthma, Eur Respir J 32 : 344-349, 2008
  pubmed

• 22) Contoli MC. Baraldo S, Marku B, et al. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease : 5-year follow-up. J Allergy Clin Immunol 125 : 830-837, 2010
  pubmed

P.60 掲載の参考文献

• 1) 日本呼吸ケア・リハビリテーション学会呼吸リハビリテーション委員会ワーキンググループ. 日本呼吸器学会呼吸管理学術部会. 日本リハビリテーション医学会呼吸リハビリテーションガイドライン策定委員会. 日本理学療法士協会呼吸理学療法診療ガイドライン作成委員会 : 呼吸リハビリテーションマニュアル-運動療法-第2版. 照林社. 東京, 2012 :

• 2) Cooper KH : A means of assessing maximal oxygen intake. Correlation between field and treadmill testing. JAMA : the journal of the American Medical Association, 203 : 201-204, 1968.

• 3) Laboratories ATSCoPSfCPF : Ats statement : Guidelines for the six-minute walk test. American journal of respiratory and critical care medicine, 166 : 111-117. 2002.
  pubmed

• 4) Singh SJ, Morgan MD, Scott S, Walters D, Hardman AE : Development of a shuttle walking test of disability in patients with chronic airways obstruction. Thorax, 47 : 1019-1024, 1992.
  pubmed

第二章 疾患と呼吸機能検査所見

P.69 掲載の参考文献

• 1) 日本呼吸器学会 COPDガイドライン第3版作成委員会, 編. COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 第3版. 株式会社メディカルレビュー社. 東京 : 2009

• 2) Tanabe N. Muro S, Fuseya Y, Sato S, Oguma T, Kiyokawa H, Takahashi T, Kinose D, Hoshino Y, Kubo T, Hirai T, Mishima M. Peri-diaphragmatic lung volume assessed by computed tolnography correlates with quality of life in patients with chronic obstructive pullnonary disease. Respirology : 2012 Jul 4. (doi : 10.1111/j. 1440-1843. 2012. 02221. x.)

• 3) Tanabe N, Muro S, Oguma T, Sato S, Kiyokawa H, Takahashi T, Kudo M, Kinose D, Kubo T, Hoshino Y, Ogawa E, Hirai T, Mishima M. Computed tomography assessment of pharmacological lung volume reduction induced by bronchodilators in COPD. COPD : 2012 Apr l8. (Epub ahead of print)

P.75 掲載の参考文献

• 1) Global Initiative for Asthma (GINA). Global Strategy for Asthma Management and Prevention NHLBI/WHO Work-shop Report Updated 2006. U. S. Department of Health and Human Services, Public Health Services. National Institute of Health, National Heart, Lung, and Blood Institute : 2006

• 2) 喘息予防・管理ガイドライン2009 : 社団法人日本アレルギー学会 喘息ガイドライン専門部会, 監修. 協和企画. 東京 : 2009

• 3) 臨床呼吸機能検査 第7版. 日本呼吸器学会肺生理専門委員会, 編. メディカルレビュー社. 東京 : 2008

• 4) COPD (慢性閉塞性肺疾患) 診断と治療のためのガイドライン 第3版. 社団法人日本呼吸器学会COPD ガイドライン第3版作成委員会, 編. メディカルレビュー社. 東京 : 2009

• 5) Matsunaga K, Kanda M, Hayata A, et al. Peak expiratory flow variability adjusted by forced expiratory volume in one second is a good index for airway responsiveness in asthmatics. Intern Med 47 : 1107-1112, 2008
  pubmed

• 6) Thamrin C, Taylor DR, Jones ST, et al. Variability of lung function predicts loss of asthma control following withdrawal of inhaled corticosteroid treatment. Thorax 65 : 403-408, 2010

• 7) MURRAY & NADEL's Textbook of Respiratory Medicine. 5th ed, SAUNDERS ELSEVIER. USA : 2010

P.80 掲載の参考文献

• 1) 日本呼吸器学会びまん性肺疾患診断・治療ガイドライン作成委員会. 特発性間質性肺炎 診断と治療の手引き 改訂第2版. 南江堂 : 2011

• 2) 日本呼吸器学会肺生理専門委員会. 呼吸機能検査ガイドライン, メディカルレビュー社 : 2004

• 3) 日本呼吸器学会肺生理専門委員会. 臨床呼吸機能検査. 第7版. メディカルレビュー社 : 2008

• 4) Lung Function Testing. European, Respiratory, Monography 10 (31) : 2005

• 5) Latsi PI, du Bois RM, Nicholson AG, Colby TV, Bisirtzoglou D, Nikolakopoulou A, Veeraraghavan S, Hansell DM, Wells AU. Fibrotic idiopathic interstitial pneumonia : the prognostic value of longitudinal functional trends. Am J Respir Crit Care Med 1 ; 168 (5) : 531-537, 2003

• 6) Nathan SD, Shlobin OA. Weir N, Ahmad S, Kaldjob JM, Battle E, Sheridan MJ, du Bois RM. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest 140 (1) : 221-229, 2011
  pubmed

• 7) Raghu G, Collard HR, Egan JJ, Martinez FJ, Behr J, Brown KK, Colby TV, Cordier JF, Flahcrty KR. Lasky JA, Lynch DA, Ryu JH, Swigris JJ, Wells AU, Ancochea J, Bouros D, Carvalho C, Costabel U, Ebina M, Hansell DM, Johkoh T, Kim DS, King TE Jr, Kondoh Y, Myers J, Muller NL, Nicholson AG, Richeldi L, Selman M, Dudden RF, Griss BS, Protzko SL, Schunemann HJ. ATS/ERS/JRS/ALAT Committee on Idiopathic Pulmonary Fibrosis. An official ATS/ERS/JRS/ALAT statement : idiopathic pulmonary fibrosis : evidence-based guidelines for diagnosis and management. Am J Respir Crit Care Med 15 ; 183 (6) : 788-824, 2011

• 8) Demedts M, Behr J, Buhl R, Costabel U, Dekhuijzen R, Jansen HM, MacNee W, Thomeer M, Wallaert B, Laurent F, Nicholson AG, Verbeken EK, Verschakelen J, Flower CD, Capron F, Petruzzelli S, De Vuyst P, van den Bosch JM, Rodriguez-Becerra E. Corvasce G, Lankhorst I, Sardina M, Montanari M ; IFIGENIA Study Group. High-dose acetylcysteine in idiopathic pulmonary fibrosis. N Engl J Med 24 ; 353 (21) : 2229-2242, 2005

P.84 掲載の参考文献

• 1) Grillo HC, Mark EJ, Mathisen DJ, et al. Idiopathic laryngotracheal stenosis and its management. Ann Thorac Surg 56 : 80-87, 1993
  pubmed

• 2) Bhalla M, Grillo HC. McLoud TC, et al. Idiopathic laryngotracheal stenosis : Radiologic findings. Am J Radiol 161 : 515-517, 1993

• 3) Kryger M, Bode F, Antic R, et al. Diagnosis of obstruction of the upper and central airways. Am J Med 61 : 85-93, 1976

• 4) 桑平一郎. 呼吸機能検査「原理の理解から実践と解釈まで」スパイロメトリーとフローボリューム曲線. 呼吸 29 (6) : 612-624, 2010

• 5) Toohill RJ, Ulualp SO, Shaker R. Evaluation of gastroesophageal reflux in patients with laryngotracheal stenosis. Ann Otol Rhinol Laryngol 107 : 1010-1014, 1998
  pubmed

• 6) Terra RM, de Medeiros IL, Minamoto H, et al. Idiopathic tracheal stenosis : successful outcome with antigastroesophageal reflux disease therapy. Ann Thorac Surg 85 : 1438-1439, 2008
  pubmed

• 7) Damrose EJ. On the development of idiopathic subglottic stenosis. Med Hypotheses 71 (1) : 122-125, 2008
  pubmed

• 8) Cobb WB, Sudderth JF. Intralesional steroids in laryngeal stenosis. A preliminary report. Arch Otolaryng 96 : 52-56, 1972
  pubmed

• 9) Benjamin B, Jacobson I, Eckstein R. Idiopathic subglottic stenosis : diagnosis and endoscopic laser treatment. Ann Otol Rhinol Laryngol 106 : 770-774, 1997
  pubmed

• 10) 馬上喜裕 桑平一郎 岩元徳全ほか. 特発性気管狭窄の1例. 日呼吸会誌 38 (11) : 828-830, 2000
  Medical*Online

P.88 掲載の参考文献

• 1) Trapnell BC, Whitsett JA, Nakata K. Pulmonary Alveolar Proteinosis. N Engl J Med 349 : 2527-2539, 2003
  pubmed

• 2) Inoue Y, Trapnell BC, Tazawa R, et al. Characteristics of a large cohort of patients with autoimmune pulmonary alveolar proteinosis in Japan. Am J Respir Crit Care Med 177 : 752-762, 2008
  pubmed

• 3) Nara M, Sano K, Ogawa H, et al. Serum antibody against granulocyte/macrophage colony-stimulating factor and KL-6 in idiopathic pulmonary alveolar proteinosis. Tohoku J Exp Med 208 : 349-354, 2006
  pubmed

• 4) Nakajima M, Manabe T, Niki Y, et al. Serum KL-6 level as a monitoring marker in a patients with pulmonary alveolar proteinosis. Thorax 53 : 809-811, 1998

• 5) Arai T, Hamano E, Inoue Y, et al. Serum neutralizing capacity of GM-CSF reflects disease severity in a patient with pulmonary alveolar proteinosis successfully treated with inhaled GM-CSF. Respir Med 98 : 1227- 1230, 2004